Page 139 - MemoriaESP-Eng
P. 139




www.ciberesp.es


• International consortiums (InterLymph, Internacional Multiple Myeloma Consortium, 

Hodgkin Lymphoma Consortium).

- Comprehensive evaluation of risk factors and different histologic lymphoma subty- 
pes within an international consortium (InterLymph NHL Subtype Project).

- Evaluation of hormonal and reproductive factors in multiple myeloma etiology (In- 

ternacional Multiple Myeloma Consortium).

- Gene and environment interaction studies. 

- GWAS studies on follicular lymphoma, Hodgkin lymphoma and other subtypes.




Most relevant • AleMAny l, De sAnJosé s, tous s, quint W, VAlleJos c, sHin Hr. Time trends of human 
papillomavirus types in invasive cervical cancer, from 1940 to 2007.Int J Cancer. 
scientific 
2013 Nov 28;.
articles
• cAstellsAgué x, pAWlitA M, rourA e, MArgAll n, WAterboer t, boscH Fx. Prospective se- 

roepidemiologic study on the role of Human Papillomavirus and other infections in 
cervical carcinogenesis: Evidence from the EPIC cohort.Int J Cancer. 2013 Dec 13;.

• M A, g sl, s cW, e s K, s s, K e. Exposure 
onnereAulAsercHuppKströMMeDbyDe AnJoséAne
to UV radiation and risk of Hodgkin lymphoma: a pooled analysis.Blood. 2013 Nov 
14;122(20):3492-9.

• r c, V r, M n, s Dt, t A, g-c r. Bladder cancer 
oblesisciDiAlAtsilVerMAnArDónArcíAlosAs
and seroreactivity to BK, JC and Merkel cell polyomaviruses: the Spanish bladder é
cancer study.Int J Cancer. 2013 Aug 1;133(3):597-603.

• r e, c x, p M, t n, W t, M n. Smoking as a 
ourAAstellsAguAWlitArAVierAterboerArgAll
major risk factor for cervical cancer and pre-cancer: Results from the EPIC cohort. 

Int J Cancer. 2013 Dec 13;.




The Group 36 carries out studies in two major research areas:
Highlights
• Epidemiology, etiology, prevention and control of HPV-related diseases research 
studies: Epidemiological studies on worldwide viral and strains distribution including 

participation and coordination of international studies on vaccination and the evaluation 

of the screening activities in Catalonia and monitoring the implementation of HPV 
vaccines in Catalonia (phase III and IV studies). Additionally, the group is leading 

studies on economic evaluation and modelling of cervical cancer prevention measures 
in Catalonia, Spain and other worldwide geographical regions. Likewise, the group leads 

the Information Centre on HPV and Cancer (http://www.hpvcentre.net/) on disease 
burden and carries out training and dissemination activities through the coordination 

and publication of monographs on HPV as well as an online educational program on 
oncology (http://www.e-oncologia.org/).

• Lymphoma epidemiology and etiology research studies: The group is involved in several 13
20
multicenter studies: a) Within MCC_Spain coordinating the work associated to chronic T 
OR
lymphocityc leukaemia (CLL) and participates actively in the infections, family history, P
occupational, and reproductive factors working groups associated to prostate, colon, RE
L 
stomach and breast cancer; b) The EpiLymph study (non Hodgkin lymphoma, Hodgkin A
lymphoma and multiple myeloma) and its international enlargement (InterLymph). NU
N
Interlymph is now producing a monograph on a comprenhensive evaluation of risk  A
factors and different lymphoma subtypes, including more than 24,000 controls and P /
S
17,000 cases, is being finalished. The group is also working on several ongoing projects RE
on gene and environment interaction in GWAS studies.
E
IB
• The eBLEM study on endemic Burkitt lymphoma within the CREAL-ISGLOBAL and ICO C

collaboration exploring infectious, in particular EBV, and environmental interactions in 139

Mozambique.





   137   138   139   140   141